Oligoribonucleotides and uses thereof

Details for Australian Patent Application No. 2007353120 (hide)

Owner Coley Pharmaceutical GmbH

Inventors Jurk, Marion; Uhlmann, Eugen; Vollmer, Jorg

Agent Spruson & Ferguson

Pub. Number AU-A-2007353120

PCT Pub. Number WO2008/139262

Priority 60/854,585 26.10.06 US

Filing date 26 October 2007

Wipo publication date 20 November 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/139262 Priority application(s): WO2008/139262

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007353124-Purified molybdenum technical oxide from molybdenite

2007353089-Power conversion system